NSE filing, NSE: IIFLCAPS. Summary written from the filing by ALFA Finder's alert engine.
IIFL Capital Services Ltd: key numbers
- Share price
- ₹350.60
- Market cap
- ₹13,066 Cr
- Revenue (annual)
- ₹2,420 Cr
- Net profit (annual)
- ₹561.4 Cr
- P/E (TTM)
- 21.3×Sector 20.5×
- Promoter holding
- 25.80%-4.87% QoQ
- FII holding
- 11.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IIFL Capital Services Ltd
All →IIFL Capital Services Open Offer
The Manager to IIFL Capital Services' open offer disclosed 1,17,258 shares, 0.12% of offer size, tendered in the escrow demat account. Tendered shares remain subject to validation and may differ from shares finally accepted.
IIFL Capital Services Other Announcement
IIFL Capital Services' shareholding pattern as of 4 November 2026 shows FIH Mauritius Investments set to become a promoter after a preferential allotment of 5.71 crore shares. The filing is a Reg 31 quarterly shareholding statement that records the transition.
IIFL Capital Services Preferential Issue
IIFL Capital Services allotted 5.71 crore equity shares at ₹350/share to FIH Mauritius, raising ₹1,999.99 Crore via preferential issue.
- Value
- ₹2,000 Cr
IIFL Capital Services Employee Stock Options
IIFL Capital Services granted 29,713 ESOPs and allotted 180,499 shares on exercise under its 2018 ESOS scheme. The equity base rose to 315,532,512 shares of ₹2 each.
IIFL Capital Services Open Offer: ₹3,505 Cr
FIH Mauritius and HWIC launched a 26% open offer for IIFL Capital Services at Rs.350 per share. Up to Rs.3,505 Crore; tendering opens November 2.
- Value
- ₹3,505 Cr
IIFL Capital Services Adverse Business Impact
IIFL Capital Services' subsidiary surrendered its SEBI Investment Adviser registration, effective October 28, 2026. The company states there is no material monetary impact and no penalty.
Other regulatory approval announcements
All →Sandur Manganese & Iron Ores Regulatory Approval
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
- iron ore RoM capacity
- 9.42 MTPA
Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Arihant Capital Markets Regulatory Approval
Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.
Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.
Emmbi Industries Regulatory Approval
SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.